GC Biopharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 25, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,924,262	2,048,665	1,432,354	1,478,007	2,488,073	4,633,750
Market Cap Growth	21.03%	43.03%	-3.09%	-40.60%	-46.30%	206.42%
Enterprise Value	3,068,824	3,129,049	2,368,951	2,204,898	3,075,936	5,228,112
Last Close Price	168600.00	179500.00	124404.89	126814.61	210762.41	388984.60
PE Ratio	34.16	-	-	22.58	20.19	57.17
Forward PE	41.54	87.99	47.35	21.09	25.00	33.91
PS Ratio	0.99	1.22	0.88	0.86	1.62	3.08
PB Ratio	1.29	1.38	0.93	0.94	1.66	3.65
P/TBV Ratio	2.23	1.94	1.34	1.33	2.31	4.30
P/FCF Ratio	53.33	-	-	24.17	105.17	-
P/OCF Ratio	20.96	-	-	12.40	19.75	128.81
PEG Ratio	-	1.35	1.35	1.35	1.20	0.45
EV/Sales Ratio	1.59	1.86	1.46	1.29	2.00	3.48
EV/EBITDA Ratio	16.75	27.67	21.57	15.12	23.73	52.82
EV/EBIT Ratio	32.28	97.66	69.86	27.32	41.72	104.18
EV/FCF Ratio	85.05	-	-	36.05	130.02	-
Debt / Equity Ratio	0.69	0.56	0.47	0.37	0.40	0.45
Debt / EBITDA Ratio	7.25	7.32	6.59	3.95	4.68	5.72
Debt / FCF Ratio	28.35	-	-	9.41	25.64	-
Net Debt / Equity Ratio	0.64	0.54	0.43	0.30	0.27	0.25
Net Debt / EBITDA Ratio	6.76	7.11	6.09	3.18	3.11	3.14
Net Debt / FCF Ratio	26.45	-9.41	-7.91	7.57	17.06	-6.63
Asset Turnover	0.65	0.62	0.63	0.69	0.67	0.73
Inventory Turnover	1.84	1.90	2.38	2.52	2.28	2.52
Quick Ratio	0.49	0.55	0.58	0.96	1.13	1.15
Current Ratio	1.18	1.56	1.20	1.81	1.97	1.92
Return on Equity (ROE)	2.28%	-2.82%	-1.27%	4.53%	9.89%	7.26%
Return on Assets (ROA)	1.11%	0.74%	0.82%	2.02%	2.00%	1.53%
Return on Invested Capital (ROIC)	2.14%	1.43%	1.60%	3.32%	3.36%	2.76%
Return on Capital Employed (ROCE)	2.80%	1.60%	1.90%	4.10%	3.90%	3.20%
Earnings Yield	2.93%	-1.28%	-1.86%	4.43%	4.95%	1.75%
FCF Yield	1.88%	-4.17%	-5.90%	4.14%	0.95%	-1.01%
Dividend Yield	0.85%	0.84%	-	-	-	-
Payout Ratio	33.43%	-	-	36.65%	15.02%	15.69%
Total Shareholder Return	0.87%	0.84%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.